RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY

被引:0
|
作者
Von Allwoerden, K. [1 ]
Klapa, S. [1 ]
Werth, S. C. [2 ]
Mueller, A. [1 ]
Riemekasten, G. [1 ]
Nitschke, M. [2 ]
Thaci, D. [3 ]
Lamprecht, P. [1 ]
机构
[1] Univ Lubeck, Rheumatol, Lubeck, Germany
[2] Univ Lubeck, Nephrol, Lubeck, Germany
[3] Univ Lubeck, Entzundungsmed, Lubeck, Germany
关键词
Real-world evidence; Quality of care; Vasculitis;
D O I
10.1136/annrheumdis-2023-eular.3867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1161
引用
收藏
页码:912 / 913
页数:2
相关论文
共 50 条
  • [31] Rituximab versus azathioprine for maintenance therapy in ANCA-associated vasculitis
    Clark, Anna
    LANCET RHEUMATOLOGY, 2020, 2 (01): : E12 - E12
  • [32] AVACOPAN IN ANCA-ASSOCIATED VASCULITIS RECEIVED INTENSIFIED INDUCTION THERAPY WITH CYCLOPHOSPHAMIDE PLUS RITUXIMAB - RETROSPECTIVE OBSERVATION TWO-CENTRE STUDY OF 30 PATIENTS
    Assmann, G.
    El-Baraa, A.
    Peter, K.
    Ryszard, T.
    Joerg, R.
    Schmidt, M.
    Lamprecht, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [33] Rituximab for Induction Therapy of ANCA-Associated Vasculitis: Practical Issues in the Asia Pacific Region
    Ho, Cheuk Man
    Mok, Chi Chiu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (12)
  • [34] Rituximab versus azathioprine for ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (05): : e252 - e252
  • [35] LOW-DOSE RITUXIMAB AS INDUCTION THERAPY FOR JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Takakuwa, Y.
    Hanaoka, H.
    Kiyokawa, T.
    Ishimori, K.
    Iida, H.
    Nagafuchi, H.
    Okazaki, T.
    Ozaki, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1260 - 1260
  • [36] Rituximab remission strategies in ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (02): : E71 - E71
  • [38] Rituximab in ANCA-Associated Vasculitis: Fad or Fact?
    Fervenza, Fernando C.
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C182 - C188
  • [39] Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide
    Nettleton, Elizabeth
    Sattui, Sebastian E.
    Wallace, Zachary
    Putman, Michael
    ARTHRITIS CARE & RESEARCH, 2024, 76 (02) : 288 - 294
  • [40] Recommendations on the use of rituximab for ANCA-associated vasculitis
    Gause, A. M.
    Rubbert-Roth, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (03): : 287 - 289